Abstract
Anti-Microbial Resistance (AMR) is one of the most pressing social challenges facing public health today, with 4.71 million AMR associated deaths taking place in 2021, a number which rises year by year. Our research found two ecosystems exist to combat AMR; An innovation ecosystem, looking to innovate new antimicrobial drugs, and a control ecosystem looking to ensure access and stewardship for antimicrobials. These ecosystems exist in a very co-dependent manner, and yet cross-ecosystem collaboration rarely occurs, exposing a gap in the AMR space which could potentially streamline tackling the issue. This paper highlights how inter-organization relationships (IORs) could fill this gap, whilst touching on the paradoxical reasons these IORs are not already in place.